BDSAX
Price
$20.17
Change
-$0.24 (-1.18%)
Updated
Oct 7 closing price
Net Assets
4.35B
VRTIX
Price
$377.47
Change
-$4.27 (-1.12%)
Updated
Oct 7 closing price
Net Assets
13.58B
Interact to see
Advertisement

BDSAX vs VRTIX

Header iconBDSAX vs VRTIX Comparison
Open Charts BDSAX vs VRTIXBanner chart's image
BlackRock Advantage Small Cap Core Inv A
Price$20.17
Change-$0.24 (-1.18%)
VolumeN/A
Net Assets4.35B
Vanguard Russell 2000 Index I
Price$377.47
Change-$4.27 (-1.12%)
VolumeN/A
Net Assets13.58B
BDSAX vs VRTIX Comparison Chart in %
View a ticker or compare two or three
VS
BDSAX vs. VRTIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSAX is a Buy and VRTIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTIX has more cash in the bank: 13.6B vs. BDSAX (4.35B). VRTIX pays higher dividends than BDSAX: VRTIX (1.20) vs BDSAX (0.51). BDSAX was incepted earlier than VRTIX: BDSAX (13 years) vs VRTIX (15 years). BDSAX (0.93) is less costly to investors than VRTIX (0.07). BDSAX is a more actively managed with annual turnover of: 88.00 vs. VRTIX (12.00). BDSAX has a lower initial minimum investment than VRTIX: BDSAX (1000) vs VRTIX (5000000). VRTIX annual gain was more profitable for investors over the last year : 13.81 vs. BDSAX (13.05). VRTIX return over 5 years is better than : 55.34 vs. BDSAX (38.56).
BDSAXVRTIXBDSAX / VRTIX
Total Expense Ratio0.750.071,071%
Annual Report Gross Expense Ratio0.930.071,329%
Fund Existence13 years15 years-
Gain YTD11.82911.874100%
Front Load5%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.35B13.6B32%
Annual Yield % from dividends0.511.2042%
Returns for 1 year13.0513.8195%
Returns for 3 years52.1747.99109%
Returns for 5 years38.5655.3470%
Returns for 10 years92.37123.0775%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMIDX18.41N/A
N/A
Brown Advisory Mid-Cap Growth Investor
SLANX34.06N/A
N/A
DWS Latin America Equity A
FTDZX160.73N/A
N/A
Franklin Biotechnology Discovery Adv
FGKMX144.05N/A
N/A
Fidelity Advisor Communication ServicesZ
MLACX4.92-0.03
-0.61%
NYLI Winslow Large Cap Growth Class C